The Carlyle group has agreed to sell Mitsubishi Chemical Holdings Corporation all outstanding shares of pharmaceutical capsule manufacturer Qualicaps. Products manufactured by Qualicaps include both gelatin and hypromellose capsules for use with dry powder inhalers.
Mitsubishi will pay approximately ¥55.8 billion, or about $660 million, for the company.
Read the Mitsubishi press release.
